Hospital partnership wants to boost existing work at Queen’s University

Two men in suits sit in a meeting room on chairs. The crowd behind them is standing. Everyone's attention is directed somewhere out of frame.
Dr. Claudio Soares, right, the new centre’s director, sits during the Aug. 7, 2024 opening with Dr. Tom Mikkelsen, president and CEO of the Ontario Brain Institute. (Submitted by Providence Care)

A Kingston, Ont., hospital network and university are opening a new medical psychedelics research centre.

The Centre for Psychedelics Health and Research launched Wednesday at the eastern Ontario city’s Providence Care Hospital.

Psychedelics are drugs that cause psychological effects in the person who consumes them, such as hallucinations.

Indigenous people have been using psychedelics as healing tools for millenia.

Canadian researchers have been studying the effects of drugs such as psilocybin (the psychoactive compound in magic mushrooms), LSD and ketamine on mental health conditions. While those three are controlled substances, Health Canada can allow their use in medical trials.

Queen’s Dean of Health Sciences Dr. Jane Philpott said in a news release the centre will be an important step toward building a “knowledge base” to support patients struggling with mental health and substance use.

A woman holding a microphone speaks to a room.
Dr. Jane Philpott, Dean of Health Sciences at Queen’s University, speaks at the centre’s opening. (Submitted by Providence Care)

The news release said the centre plans to train health-care professionals to use psychedelics as a therapeutic tool, host community workshops to share knowledge and fight the stigma associated with psychedelics.

It also mentioned chronic pain and palliative care as areas it’s interested in.

WATCH | A look at a company that helps run trials:

What’s behind the push for more magic mushrooms research

6 months ago

Duration7:56

Health Canada is facing pressure to speed up research into the therapeutic potential of magic mushrooms to help people facing significant mental health issues, including PTSD. CBC’s Joel Ballard visits a legal psilocybin grow-op and breaks down the demand, the potential benefits and the red tape.

The centre’s new director Dr. Claudio Soares, the chair of a psychedelics science committee at the school, wrote he believes the new centre will help Canada “make informed choices about the efficacy and safety of psychedelics in the future.”

The centre also has support from the Ontario Brain Institute and the Canadian Biomarker Integration Network in Depression, where Soares is a founder and executive.

Though the centre opened Wednesday, it’s in its early days; it still needs to be outfitted to conduct the trials and other work it hopes to host.

ABOUT THE AUTHOR

Gabrielle is an Ottawa-based journalist with eclectic interests. She’s spoken to video game developers, city councillors, neuroscientists and small business owners alike. Reach out to her for any reason at gabrielle.huston@cbc.ca.

 

https://www.cbc.ca/news/canada/ottawa/kingston-ontario-queens-psychedelics-research-1.7286865

Pin It on Pinterest